Blue-Gray Mucocutaneous Discoloration: A New Adverse Effect of Ezogabine
The DOI matches its Crossref record.
Abstract
IMPORTANCE: Many drugs have been reported to induce skin and/or mucous membrane discoloration. Ezogabine (retigabine) was recently approved as an add-on drug for the treatment of partial seizures in adults with epilepsy. Mucocutaneous discoloration induced by antiepileptic drugs in general and ezogabine in particular has not been previously reported. OBSERVATIONS: Two patients who had received multiple antiepileptic drugs for several years presented with a blue-gray skin dyspigmentation that was most pronounced on the face and lips and was associated with nail pigmentation, blue pigmentation on the hard palate, and black pigment deposits on the conjuctivae. The sole drug common to the therapeutic regimens of both patients was ezogabine. Histopathologically, the main finding was perivascular and periadnexal dermal cells heavily laden with coarse melanin granules, which appeared ultrastructurally as intracellular electron-dense granules. Four months after discontinuing ezogabine, our first patient showed a significant improvement in the mucocutaneous and nail dyspigmentation. CONCLUSIONS AND RELEVANCE: The temporal relationship, clinical features, histologic and ultrastructure findings, and improvement following withdrawal of ezogabine indicate that the dyspigmentation was drug induced. Ezogabine should be added to the list of drugs that can induce mucocutaneous discoloration. The incidence of this significant adverse effect requires further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The genetic landscape of the epileptic encephalopathies of infancy and childhood
McTague, A., Howell, K. B., Cross, J. H., Kurian, M. A., & Scheffer, I. E. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00250-1 · Cited by 604
Manford, M. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8394-2 · Cited by 299
Targeting Kv7 Potassium Channels for Epilepsy
Perucca, E., & Taglialatela, M. (2025) · CNS Drugs · doi:10.1007/s40263-024-01155-3 · Cited by 43
Liu, Y., Bian, X., & Wang, K. (2021) · Handbook of Experimental Pharmacology · doi:10.1007/164_2021_458 · Cited by 36
Wang, X., Zhang, Y., Liu, H., Wang, J., Zhang, B., He, T., Zhang, H., Xiong, Z., Liu, X., Li, J., et al. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70334 · Cited by 2
Metadata
- Authors
- Garin Shkolnik, T., Feuerman, H., Didkovsky, E., Kaplan, I., Bergman, R., Pavlovsky, L., & Hodak, E.
- Venue
- JAMA Dermatology
- Publisher
- American Medical Association (AMA)
- Published
- 2014-09-01
- Volume
- 150
- Issue
- 9
- Pages
- 984
- ISSN
- 2168-6068 (ISSN-L)
- OpenAlex
- W2038150965
- Cited by
- 86
- References
- 0
- FWCI
- 5.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Blue-Gray Mucocutaneous Discoloration: A New Adverse Effect of Ezogabine. https://app.cochat.ai/papers/10.1001/jamadermatol.2013.8895
- The paper
- Garin Shkolnik, T., Feuerman, H., Didkovsky, E., Kaplan, I., Bergman, R., Pavlovsky, L., & Hodak, E. (2014). Blue-Gray Mucocutaneous Discoloration: A New Adverse Effect of Ezogabine. JAMA Dermatology. https://doi.org/10.1001/jamadermatol.2013.8895
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.